erlotinib has been researched along with lithocholic acid in 1 studies
| Studies (erlotinib) | Trials (erlotinib) | Recent Studies (post-2010) (erlotinib) | Studies (lithocholic acid) | Trials (lithocholic acid) | Recent Studies (post-2010) (lithocholic acid) |
|---|---|---|---|---|---|
| 221 | 0 | 180 | 1,111 | 24 | 280 |
| Protein | Taxonomy | erlotinib (IC50) | lithocholic acid (IC50) |
|---|---|---|---|
| carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 isoform 1 | Homo sapiens (human) | 4.823 | |
| 60 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 10 | |
| Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 6.12 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 2.71 | |
| 10 kDa heat shock protein, mitochondrial | Homo sapiens (human) | 10 | |
| Bile acid receptor | Homo sapiens (human) | 0.0183 | |
| large T antigen | Betapolyomavirus macacae | 26.1 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arya, GC; Jaitak, V; Kaur, K | 1 |
1 review(s) available for erlotinib and lithocholic acid
| Article | Year |
|---|---|
Isoxazole derivatives as anticancer agent: A review on synthetic strategies, mechanism of action and SAR studies.
Topics: Antineoplastic Agents; Apoptosis; Breast Neoplasms; Cell Proliferation; Drug Screening Assays, Antitumor; Female; Humans; Isoxazoles | 2021 |